Webinar: Diabetes and Ramadan

Man wearing headphones, watching webinar on laptop

Ramadan is the Holy Month for Muslims; a time of worship, self-discipline, austerity and charity. Fasting during the month of Ramadan is one of the five pillars of Islam and is obligatory for all Muslims.

Providing high quality pre-Ramadan education reduces the risks for people with diabetes who choose to fast. Therefore, it is vital that healthcare professionals who support people with diabetes have a good grasp of the effects of the significant changes in lifestyle during Ramadan and how diabetes management needs to be modified.

This webinar will offer practical advice and help you understand:

  • The physiological effects of fasting
  • Common changes in diet and lifestyle during Ramadan
  • Risk stratification for people choosing to fast
  • The risks of fasting and how to mitigate them
  • Adjustments in diabetes treatments

Please note: CPD will not be available for this webinar

Certificates of attendance will be issued to those who attend the live webinar.

This webinar has been instigated and organised by ABCD. The support from our corporate sponsors has allowed us to provide this valuable educational meeting free of charge to all delegates. Sponsors have had no input into the agenda or the selection of speakers.

Speakers

  • Professor Mohamed Hassanein

    image of Professor Mohamed Hassanein

    Prof Mohamad Hassanein, FRCP, CCST, MPHIL, MBCHB

    Mohamed Hassanein is a Professor of Medicine, at Mohamed Bin-Rashid University, Dubai, senior consultant in Endocrinology and Diabetes at Dubai Hospital, Dubai, since 2014 and H Professor of Medicine, Gulf Medical University, UAE. He’s also the associate Director for Postgraduate Diabetes Education, Cardiff University, UK since 2007. He was appointed to the post of Consultant in the Department of Endocrinology and Diabetes at BCUHB, UK, in 2002-2014. Dr Hassanein graduated from the Faculty of Medicine, Alexandria, Egypt.

    His main research interest is in the field of diabetes and Ramadan. He co-authored recommendations papers on this subject for the American Diabetes Association (ADA) in 2005 and 2010, and for the British Medical Journal in 2010, Diabetes Canada in 2017 as well as the IDF-DAR practical guidelines, 2016 and 2021. Dr Hassanein has participated as the first author and/or a co-author in numerous studies and guidelines including studies on prevalence of diabetes, obesity, hypertension and is the first author for the Emirates Cardiometabolic guidelines. He has published over 85 papers. He’s also the associate editor of Dubai Diabetes and Endocrinology Journal.

  • Salma Mehar

    image of Salma Mehar

    Salma Mehar RD is a diabetes project lead and dietitian at Imperial College Healthcare NHS Trust and NHS North West London Integrated Care System. She is a registered Dietitian with over 20 years of NHS experience. Her work has been acknowledged in many communities; improving long term conditions including Diabetes, heart disease and obesity through education and development of culturally specific dietary resources including the "World Food Book". Her role has extended working across the globe with Diabetes and Ramadan alliance (DaR), developing the Ramadan culturally specific Nutrition Plans and to meet the needs of individual communities. She has delivered a number of pre- Ramadan Education sessions and has a special interest in delivering digital education through mass online courses, including those with MyWay Digital Health.

  • Dr. Deborah Wake

    image of Dr. Deborah Wake

    Dr Debbie Wake is a Clinical Reader at University of Edinburgh and Diabetes Consultant, (MBChB, BSc, PhD, Clin Ed Dip), a Diabetes UK Clinical Champion, a 2017/18 NHS Innovation Accelerator Fellow and one of nine 2019 IUK Women in Innovation Award winners. She leads national programmes on diabetes artificial intelligence/ automated decision support and international diabetes education programmes. Previously, she was a health columnist for a national UK newspaper and TV doctor/ presenter for STVs ‘The Hour’ programme. She is also CEO and co-founder of MyWay Digital Health (www.mwdh.co.uk) (MWDH) (University of Dundee spin out company). Debbie’s vision is to improve the lives of people with diabetes globally through affordable data-driven solutions. She has developed multi-award winning software applications; including a data driven patient application deployed across 30% of the UK (called MyWayDiabetes) that has improved health outcomes and delivered significant health saving(5:1 ROI).
    https://www.ed.ac.uk/profile/debbie-wake

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd